About Serum Biomedical Institute SERUM BIOMEDICAL INSTITUTE is an advanced research and development facility located at Evinu 8, 11527, Athens, Greece. It was founded in 1988 and it specializes in the fields of and biogenetics (insert link to DNA Engineering), biochemistry, and human fertility. We originally focused primarily on our IVF Services but in the early 1990s we began to shift our emphasis to biotechnology, particularly DNA Engineering. In doing so we quickly made significant strides in the field and we have since pioneered new techniques in recombinant technology, which have filed patents on. Using our proprietary technology we have developed extremely accurate and efficient ways for vector expression of genes in both mammalian and bacterial cell lines. This can be used to produce superior grade raw material for a wide range of biopharmaceutical products such as Interferon-alfa and beta, Hepatitis-B Vaccine, Human Growth Hormone (pituitary and placental), Factor-VIII, FSH (follicle stimulating hormone), Anti-HIV Drugs and others. Our technology allows us to select only the exact DNA coding points that we require without having to include any unwanted DNA material in our selected working strand. This means that we can create precisely designed recombinant proteins which are accurately tailored to our exact requirements for the production of genetic raw material to produce new, more effective recombinant pharmaceuticals. Our technology also gives us the ability to easily design and create chimeric (fused) molecules of DNA expressing the characteristics of two entirely different proteins in a single chain or even expressing only the active centers of these proteins. We Offer Pharmaceutical Companies The Opportunity To Produce Superior Pharmaceuticals At A Lower Cost We create new and more target specific recombinant pharmaceuticals with a significantly increased and precise focus which until now was not possible to achieve. Research shows that our proteins have a much greater biological activity (potency) per unit that anything presently available, and that the yield from them under normal production conditions is several times greater than current standards. This translates into more potent (superior quality) pharmaceutical raw material which can be produced in greater quantities under normal conditions, in other words we can achieve better quality products at lower production costs. Virtually all of the products derived from this are patentable and the ones that may not be are better and cheaper than their competitors thus they will command the market anyway. The overall commercial value? You decide.
HOME || ABOUT US || OUR TECHNOLOGY || DNA ENGINEERING || IVF SERVICES || CONTACT US VISIT OUR GREEK SITE HERE